Related Experiment Video
Updated: Jul 11, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
Published on: April 2, 2017
Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated
Michihiro Nonaka1, Susumu Tazuma, Hideyuki Hyogo
1Department of Medicine, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
Background And Aim:
Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands inhibit cell growth and induce apoptosis in various cancer cells. Bile acids are also known to cause hepatocyte apoptosis through nuclear receptor-mediated mechanisms. The aim of this study was to examine the effect of two different bile acid species on the inhibitory action of PPARgamma in cell growth with paying attention to the role of the mitogen-activated protein kinase pathway as an underlying mechanism.
Methods:
Immortalized human hepatocytes (OUMS-29) and hepatoma cells (HepG2 and Huh7) were incubated with troglitazone (TGZ), a PPARgamma ligand with or without pre-incubation of either hydrophobic glycochenodeoxycholate (GCDC) or hydrophilic tauroursodeoxycholate (TUDC).
Results:
TGZ induced cell apoptosis in all cell types, resulting in the reduction of cell viability. While pre-incubation with GCDC enhanced the apoptotic effects of TGZ, TUDC significantly attenuated it. Both bile acids enhanced p38 and c-Jun N-terminal kinase (JNK) phosphorylation in a similar way, whereas there was more drastic enhancement of extracellular signal-regulated kinase (ERK) 1/2 phosphorylation in the presence of TUDC compared to GCDC. In addition, ERK inhibitors suppressed the action of TUDC against apoptotic effect of TGZ.
Conclusion:
This study demonstrates that TUDC exhibits anti-apoptotic and cytoprotective effects against TGZ-induced cell apoptosis, presumably through the ERK signaling pathway. We speculate that the administration of TUDC might be one of the potential strategies for the hepatotoxicity caused by TGZ.
Insights
Tauroursodeoxycholate (TUDC) reduces troglitazone-induced apoptosis in liver cells, likely via the ERK pathway. This suggests TUDC may mitigate drug-induced liver toxicity.
Area of Science:
- Hepatology
- Molecular Biology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands inhibit cancer cell growth and induce apoptosis.
- Bile acids can induce hepatocyte apoptosis via nuclear receptor mechanisms.
Purpose of the Study:
- To investigate the effect of two bile acids on PPARgamma-mediated growth inhibition.
- To explore the role of the mitogen-activated protein kinase (MAPK) pathway in this interaction.
Main Methods:
- Hepatocytes and hepatoma cells were treated with troglitazone (TGZ), a PPARgamma ligand.
- Cells were pre-incubated with glycochenodeoxycholate (GCDC) or tauroursodeoxycholate (TUDC).
- MAPK pathway phosphorylation (p38, JNK, ERK) was analyzed.
Main Results:
- TGZ reduced cell viability and induced apoptosis.
- GCDC enhanced TGZ-induced apoptosis, while TUDC attenuated it.
- TUDC significantly enhanced ERK1/2 phosphorylation, an effect reversed by ERK inhibitors.
Conclusions:
- TUDC exhibits anti-apoptotic and cytoprotective effects against TGZ-induced apoptosis.
- The ERK signaling pathway is implicated in TUDC's protective mechanism.
- TUDC may be a potential strategy to manage TGZ-induced hepatotoxicity.
Related Concept Videos
Peroxisomes
Bioactivation and Tissue Toxicity
GPCR Desensitization